1.Liver transplantation for advanced hepatocellular carcinoma.
Clinical and Molecular Hepatology 2016;22(3):309-318
There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.
Biomarkers, Tumor/analysis
;
Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy
;
Humans
;
Liver Neoplasms/diagnostic imaging/pathology/*therapy
;
Liver Transplantation
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Patient Selection
;
Positron-Emission Tomography
2.Laser-induced interstitial thermotherapy via a single-needle delivery system: Optimal conditions of ablation, pathological and ultrasonic changes.
Yan-Rong ZHANG ; Ling-Yun FANG ; Cheng YU ; Zhen-Xing SUN ; Yan HUANG ; Juan CHEN ; Tao GUO ; Fei-Xiang XIANG ; Jing WANG ; Cheng-Fa LU ; Tian-Wei YAN ; Qing LV ; Ming-Xing XIE
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(4):579-584
This study aimed to examine the optimal conditions of laser-induced interstitial thermotherapy (LITT) via a single-needle delivery system, and the ablation-related pathological and ultrasonic changes. Ultrasound (US)-guided LITT (EchoLaser system) was performed at the output power of 2-4 Wattage (W) for 1-10 min in ex vivo bovine liver. Based on the results of the ex vivo study, the output power of 3 and 4 W with different durations was applied to in vivo rabbit livers (n=24), and VX2 tumors implanted in the hind limbs of rabbits (n=24). The ablation area was histologically determined by hematoxylin-eosin (HE) staining. Traditional US and contrast enhanced ultrasound (CEUS) were used to evaluate the treatment outcomes. The results showed: (1) In the bovine liver, ablation disruption was grossly seen, including a strip-like ablation crater, a carbonization zone anteriorly along the fiber tip, and a surrounding gray-white coagulation zone. The coagulation area, 1.2 cm in length and 1.0 cm in width, was formed in the bovine liver subjected to the ablation at 3 W for 5 min and 4 W for 4 min, and it extended slightly with the ablation time. (2) In the rabbit liver, after LITT at 3 W for 3 min and more, the coagulation area with length greater than or equal to 1.2 cm, and width greater than or equal to 1.0 cm, was found. Similar coagulation area was seen in the implanted VX2 carcinoma at 3 W for 5 min. (3) Gross examination of the liver and carcinoma showed three distinct regions: ablation crater/carbonization, coagulation and congestion distributed from the center outwards. (4) Microscopy revealed four zones after LITT, including ablation crater/carbonization, coagulation, edema and congestion from the center outwards. A large area with coagulative necrosis was observed around a vessel in the peripheral area with edema and hyperemia. (5) The size of coagulation was consistent well to the CEUS findings. It was concluded that EchoLaser system at low power can produce a coagulation area larger than 1.0 cm×1.0 cm during a short time period. The real-time US imaging can be used to effectively guide and assess the treatment.
Animals
;
Bone Neoplasms
;
diagnostic imaging
;
pathology
;
therapy
;
Cattle
;
Hindlimb
;
pathology
;
Laser Therapy
;
instrumentation
;
methods
;
Liver Diseases
;
diagnostic imaging
;
therapy
;
Rabbits
;
Treatment Outcome
;
Ultrasonic Therapy
;
instrumentation
;
methods
;
Ultrasonography
3.A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
Clinical and Molecular Hepatology 2016;22(1):7-17
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care of the patient. Consequently, enormous heterogeneity in management trends has been observed. To support standard care for HCC, we systematically appraised 8 current guidelines for HCC around the world, including 3 guidelines from Asia, 2 from Europe, and 3 from the United States according to the selection criteria of credibility influence and multi-faceted. After a systematic appraisal, we found that these guidelines have both similarities and dissimilarities in terms of surveillance and treatment allocation recommendations due to regional differences in disease and other variables (diagnosis, staging systems) secondary to the lack of a solid, high level of evidence. In contrast to other tumors, the geographic differences in tumor biology (i.e., areas of increased hepatitis B prevalence) and available resources (organ availability for transplantation, medical technology, accessibility to treatment, health systems, and health resources) make it impractical to have an internationally universal guideline for all patients with HCC. Although Barcelona-Clinic Liver Cancer (BCLC) has long been dominant system for treatment-guiding staging of HCC, many Asia-pacific experts do not fully agree with its principle. The concepts of BCLC, for surgical resection or other locoregional therapy, are considered too conservative. Asian guidelines represent consensus about surgical resection and TACE indication for more advanced tumor.
Algorithms
;
Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy
;
Chemoembolization, Therapeutic
;
Guidelines as Topic
;
Humans
;
Liver Neoplasms/diagnosis/pathology/*therapy
;
Liver Transplantation
;
Neoplasm Staging
;
alpha-Fetoproteins/analysis
4.Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
Lauren M LADD ; Temel TIRKES ; Mark TANN ; David M AGARWAL ; Matthew S JOHNSON ; Bilal TAHIR ; Kumaresan SANDRASEGARAN
Clinical and Molecular Hepatology 2016;22(4):450-457
BACKGROUND/AIMS: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA) in the detection of HCC and the consequent management impact on potential liver transplant patients. METHODS: One hundred and sixteen HCC lesions were analyzed in 41 patients who received an orthotopic liver transplant (OLT). All of the patients underwent pretransplantation hepatic DSA, MDCT, and/or MRI. The imaging results were independently reviewed retrospectively in a blinded fashion by two interventional and two abdominal radiologists. The liver explant pathology was used as the gold standard for assessing each imaging modality. RESULTS: The sensitivity for overall HCC detection was higher for cross-sectional imaging using MRI (51.5%, 95% confidence interval [CI]=36.2-58.4%) and MDCT (49.8%, 95% CI=43.7-55.9%) than for DSA (41.7%, 95% CI=36.2-47.3%) (P=0.05). The difference in false-positive rate was not statistically significant between MRI (22%), MDCT (29%), and DSA (29%) (P=0.67). The sensitivity was significantly higher for detecting right lobe lesions than left lobe lesions for all modalities (MRI: 56.1% vs. 43.1%, MDCT: 55.0% vs. 42.0%, and DSA: 46.9% vs. 33.9%; all P<0.01). The sensitivities of the three imaging modalities were also higher for lesions ≥2 cm vs. <2 cm (MRI: 73.4% vs. 32.7%, MDCT: 66.9% vs. 33.8%, and DSA: 62.2% vs. 24.1%; all P<0.01). The interobserver correlation was rated as very good to excellent. CONCLUSIONS: The sensitivity for detecting HCC is higher for MRI and MDCT than for DSA, and so cross-sectional imaging modalities should be used to evaluate OLT candidacy.
Adult
;
Aged
;
Angiography, Digital Subtraction
;
Carcinoma, Hepatocellular/*diagnostic imaging/pathology/therapy
;
Female
;
Humans
;
Liver Neoplasms/*diagnostic imaging/pathology/therapy
;
Liver Transplantation
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Retrospective Studies
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed
5.Observation of hemodynamics after transcatheter arterial chemoembolization of primary hepatocellular carcinoma using multidetector CT perfusion imaging.
Lin YANG ; Xiao-Ming ZHANG ; Xiang-Ping ZHOU
Chinese Journal of Hepatology 2009;17(1):76-77
Adult
;
Aged
;
Antineoplastic Agents
;
administration & dosage
;
Carcinoma, Hepatocellular
;
blood supply
;
diagnostic imaging
;
therapy
;
Chemoembolization, Therapeutic
;
Female
;
Hemodynamics
;
Hepatic Artery
;
diagnostic imaging
;
pathology
;
Humans
;
Liver
;
blood supply
;
diagnostic imaging
;
pathology
;
Liver Neoplasms
;
blood supply
;
diagnostic imaging
;
therapy
;
Male
;
Middle Aged
;
Tomography, Spiral Computed
;
methods
6.Value of (18)F-FDG PET in preoperative TACE of hepatocellular carcinoma.
Zhongfei CHANG ; Peng SONG ; Maoqiang WANG ; Fengyong LIU ; Feng DUAN ; Zhijun WANG ; Yan WANG
Chinese Journal of Oncology 2014;36(5):377-381
OBJECTIVETo evaluate the prognostic significance of (18)F-FDG PET-CT SUVmax value in 85 patients with hepatocellular carcinoma (HCC) before transarterial chemoembolization (TACE).
METHODSA retrospective analysis was conducted on 85 patients with HCC before TACE to evaluate the prognostic significance of SUVmax of (18)F-FDG PET-CT. The survival rates were calculated using Kaplan-Meier method. Log-rank method was used for univariate analysis, and Cox regression model was used for multivariate analysis.
RESULTSThe patients were divided into two groups before TACE: The high metabolic group (63 patients, with SUVmax value 7.71 ± 2.78) and low metabolic group (22 patients, with SUVmax value 3.89 ± 0.80). The SUVmax levels were statistically different (P < 0.001). The 1-, 2- and 3-year survival rates of the 63 patients of high metabolic group were 66.6%, 26.9% and 12.6%, respectively. The 1-, 2- and 3-year survival rates of the 22 patients of low metabolic group were 81.8%, 72.7% and 63.6%, respectively. The median survival time of the high metabolic group was 16.0 months and that of the low metabolic group was 48.0 months (P = 0.001). Univariate analysis indicated that SUVmax value of the intrahepatic primary tumor, hepatic cirrhosis, Child-Pugh score, ECOG score, intrahepatic tumor size, number of tumors(solitary or multiple), portal vein tumor thrombus, BCLC stage, and serum AFP level were significantly correlated with prognosis of the patients (P < 0.05 for all). Multivariate analysis indicated that SUVmax value, tumor size >8 cm, number of tumors (solitary or multiple) and AFP level were independent prognostic factors (P < 0.05 for all).
CONCLUSIONThe SUVmax value of the primary intrahepatic tumor can be used as an important prognostic factor to predict the effect of TACE in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular ; diagnostic imaging ; pathology ; therapy ; Chemoembolization, Therapeutic ; Female ; Fluorodeoxyglucose F18 ; Glucose ; metabolism ; Humans ; Liver Neoplasms ; diagnostic imaging ; pathology ; therapy ; Male ; Middle Aged ; Neoplasm Staging ; Positron-Emission Tomography ; Retrospective Studies ; Survival Rate
7.Microbubbles enhanced HIFU ablation on rabbit hepatic VX2 tumors: detecting residual tumor with contrast-enhanced ultrasound and spiral CT.
Journal of Zhejiang University. Medical sciences 2013;42(3):337-344
OBJECTIVETo assess the application of gray-scale contrast-enhanced ultrasound (CEUS) and contrast-enhanced spiral computed tomography (CECT) in detection of residual tumor after high intensity focused ultrasound (HIFU) ablation with microbubbles on rabbit hepatic VX2 tumors.
METHODSForty rabbits with hepatic VX2 tumors were randomly divided into three groups before ablation. Group I (n=10) served as sham ablation controls, rabbits in group II (n=15) and group III (n=15) were ablated using HIFU under the manipulation of computer. A bolus of 0.2 ml SonoVue solution was injected via ear marginal vein of rabbits in group III before ablation. Tumors were examined with CEUS and CECT before and within 3h after HIFU ablation. Necropsy and histopathological assessment were performed immediately after the completion of images evaluation.
RESULTSBefore ablation, intense arterial feeding vessels was detected in the tumors (77.5%,31/40 Compared with 52.5%,21/40) or the periphery of the tumors (22.5%,9/40 Compared with 47.5%,19/40) by CEUS and CECT, respectively. The tumors were characterized by quick wash-in and wash-out (high and rapid peak of enhancement in the arterial phase,followed by a fast decrease in enhancement level). The dose parameters used to achieve therapeutic effect in group III were significantly lower than those in group II(P<0.01). There were local residual viable tumor tissues due to incomplete ablation in 60.0% (9/15) of group II and 13.3% (2/15) of group III revealed by histopathology(P<0.05). The concordance rate of CECT and CEUS with histopathology on residual tumor detection was 27.3% and 81.8% (P<0.05), respectively.
CONCLUSIONThe administration of microbubble agent enhances the efficacy of HIFU on rabbit hepatic VX2 tumors. CEUS is more sensitive than CECT in detection of residual viable rabbit VX2 tumor after HIFU.
Animals ; Female ; High-Intensity Focused Ultrasound Ablation ; Liver Neoplasms, Experimental ; therapy ; Male ; Microbubbles ; Neoplasm, Residual ; diagnostic imaging ; pathology ; Phospholipids ; Rabbits ; Sulfur Hexafluoride ; Tomography, Spiral Computed ; Ultrasonography
8.CT, MR and DSA imaging in the follow-up of patients with hepatocellular carcinoma well filled with lipiodol after transcatheter arterial chemoembolization.
Rong LIU ; Jianhua WANG ; Kangrong ZHOU ; Zhiping YAN
Chinese Journal of Hepatology 2002;10(2):145-145
Adult
;
Aged
;
Aged, 80 and over
;
Angiography, Digital Subtraction
;
methods
;
Carcinoma, Hepatocellular
;
diagnostic imaging
;
pathology
;
therapy
;
Catheterization
;
Chemoembolization, Therapeutic
;
Diagnostic Imaging
;
methods
;
Follow-Up Studies
;
Humans
;
Iodized Oil
;
Liver Neoplasms
;
diagnostic imaging
;
pathology
;
therapy
;
Magnetic Resonance Imaging
;
methods
;
Male
;
Middle Aged
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed
;
methods
9.The preliminary study of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma patients with portal vein tumor thrombus.
Cheng-gang WANG ; Xiao-lin WANG ; Gao-quan GONG ; Gang CHEN ; Zhao-chong ZENG ; Wei-li QIU ; Gen-lai LIN ; Yi CHEN ; Guo-ping LI
Chinese Journal of Hepatology 2009;17(6):417-421
OBJECTIVETo study the clinical efficiency of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus.
METHODS22 cases of HCC patients with portal vein tumor thrombus were devided into 2 groups: 10 patients (group A) recieved stent implantation in combination with conformal radiation therapy, 12 patients (group B) recieved stent implantation and transcatheter arterial chemoembolization. The adverse reactions, and liver function before and after treatment were compared between the two groups. The stent patency rate at 4, 6 and 12 months and the survival rate at 3, 6 and 12 months were followed up. Comparison of liver function was analyzed by Wilcoxon signed rank test. Comparison of stent patency rate curves and survival curves was analyzed by Log rank test.
RESULTSThe portal vein catheterization was successful in all the patients. The stents were successfully implanted by transhepatic portal vein approach, and portal vein stenosis was re-opened. There was no abdominal hemorrhage in all the patients, but there were symptoms of abdominalgia, fever, nausea, vomiting and flatulence of varying degrees after interventional operation, and these symptoms were relieved by symptomatic treatment in one week. All patients in group A completed the treatment. I-II degree gastrointestinal tract reactions occurred in 3 cases, I-II degree myelosuppression occurred in 2 cases, and they were all completely relieved after treatment. The stent patency rate at 4, 6 and 12 months was 90%, 70%, 30% in group A; and 50%, 25% , 16.7% in group B (P < 0.05). The survival rate at 3, 6 and 12 months was 100%, 80% , 30% in group A and 91.7%, 41.7%, 16.7% in group B (P < 0.05).
CONCLUSIONStent implantation combined with three-dimensional conformal radiation therapy is a good treatment for hepatocellular carcinoma with portal vein tumor thrombus and causes less damage to liver.
Adult ; Aged ; Carcinoma, Hepatocellular ; complications ; diagnostic imaging ; therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms ; complications ; diagnostic imaging ; therapy ; Male ; Metals ; Middle Aged ; Neoplasm Invasiveness ; Portal Vein ; pathology ; Radiography ; Radiotherapy, Conformal ; Radiotherapy, Intensity-Modulated ; Retrospective Studies ; Stents ; Survival Rate ; Treatment Outcome ; Venous Thrombosis ; diagnostic imaging ; etiology ; therapy
10.Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm.
Seawon HWANG ; Jieun LEE ; Jung Min LEE ; Sook Hee HONG ; Myung Ah LEE ; Hoo Geun CHUN ; Ho Jong CHUN ; Sung Hak LEE ; Eun Sun JUNG
The Korean Journal of Gastroenterology 2015;66(1):50-54
The occurrence of hepatocellular carcinoma (HCC) is closely associated with viral hepatitis or alcoholic hepatitis. Although active surveillance is ongoing in Korea, advanced or metastatic HCC is found at initial presentation in many patients. Metastatic HCC presents with a hypervascular intrahepatic tumor and extrahepatic lesions such as lung or lymph node metastases. Cases of HCC presenting as carcinoma of unknown primary have been rarely reported. The authors experienced a case of metastatic HCC in a patient who presented with a metastatic bone lesion but no primary intrahepatic tumor. This case suggests that HCC should be considered as a differential diagnosis when evaluating the primary origin of metastatic carcinoma.
Antineoplastic Agents/therapeutic use
;
Bone Neoplasms/*diagnosis/diagnostic imaging/secondary
;
Carcinoma, Hepatocellular/*diagnosis/drug therapy
;
Cervical Cord/pathology
;
Chemoembolization, Therapeutic
;
Gamma Rays
;
Humans
;
Liver Neoplasms/*diagnosis/drug therapy
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Neoplasms, Unknown Primary/pathology
;
Niacinamide/analogs & derivatives/therapeutic use
;
Pelvic Bones/pathology
;
Phenylurea Compounds/therapeutic use
;
Tomography, X-Ray Computed